23 Jul, 2026
According to Straits Research, the global enzymatic DNA synthesis market size was valued at $353.04 million in 2025 and is projected to grow from $423.75 million in 2026 to $1,869.72 million by 2034, registering a CAGR of 20.39% during the forecast period 2026–2034.
The global enzymatic DNA synthesis market is gaining strong momentum, driven by the escalating demand for faster, more accurate, and environmentally sustainable DNA synthesis methods. A key market driver is the growing use of synthetic biology across therapeutics, diagnostics, gene editing, data storage, and industrial biotechnology. Traditional chemical DNA synthesis faces limitations in producing long, high-fidelity sequences and generates hazardous waste. In contrast, enzymatic approaches enable rapid, cleaner, and longer DNA assembly, making them highly attractive for newer applications such as personalized medicines, CRISPR-based therapies, and DNA-based data storage.
However, the market faces a major restraint in the form of high development costs and limited commercial maturity of enzymatic synthesis platforms. EDS technologies remain relatively new and require advanced enzymes, proprietary chemistries, and sophisticated instrumentation. This results in elevated pricing and slows widespread adoption, especially among smaller research labs and early-stage biotech firms. Despite this, the market holds substantial opportunities as advancements in gene therapies and cell engineering accelerate the need for longer, precise, and rapid DNA constructs. The shift toward automated benchtop “DNA printers,” along with partnerships between technology developers and biopharmaceutical companies, is expected to open significant growth avenues during the forecast period.
sales@straitsresearch.com